Loading...
Loading...
Browse all stories on DeepNewz
VisitSector with Largest Market Share Growth Post-Divestiture Bill by Dec 31, 2025
Independent Pharmacies • 25%
Generic Drug Manufacturers • 25%
Online Pharmacies • 25%
Other • 25%
Market analysis reports from reputable financial analysts
Bipartisan Bill by Senators Warren and Hawley Forces Health Insurers, PBMs to Divest Pharmacies in Three Years
Dec 11, 2024, 02:08 PM
A bipartisan group of U.S. lawmakers, led by Senators Elizabeth Warren and Josh Hawley, is preparing to introduce legislation that would compel health insurers and pharmacy-benefit managers (PBMs) to divest their pharmacy businesses within three years. The proposed bills, to be introduced in both the Senate and the House, aim to address the conflicts of interest and market manipulation by PBMs, which have been criticized for driving up drug costs and pushing small pharmacies out of business. This move is seen as a significant intervention into the operations of PBMs, potentially reshaping the landscape of the healthcare industry by cutting off a major revenue source for these companies.
View original story
Healthcare • 25%
Pharmaceuticals • 25%
Technology • 25%
Consumer Goods • 25%
Retail • 25%
Biopharma • 25%
Technology • 25%
Other • 25%
American Battery Technology Co. • 25%
Albemarle • 25%
Forge Battery • 25%
Cabot Corporation • 25%
Talen Energy gains market share • 25%
Vistra Corp. gains market share • 25%
Constellation Energy gains market share • 25%
No significant change • 25%
Philip Morris gains market share • 25%
BAT gains market share • 25%
JTI gains market share • 25%
No significant change • 25%
Less than 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
More than 40% • 25%
Technology • 25%
Manufacturing • 25%
Energy • 25%
Other • 25%
Less than 20% • 25%
20-30% • 25%
30-40% • 25%
More than 40% • 25%
American Battery Technology Co. • 25%
Albemarle • 25%
Forge Battery • 25%
Group14 Technologies • 25%
Technology • 25%
Finance • 25%
Manufacturing • 25%
Healthcare • 25%
Technology • 25%
Healthcare • 25%
Finance • 25%
Consumer Discretionary • 25%
Technology • 25%
Healthcare • 25%
Finance • 25%
Energy • 25%
CVS Health • 25%
Express Scripts • 25%
Other • 25%
OptumRx • 25%